Literature DB >> 10024210

Paediatric, invasive pneumococcal disease in Switzerland, 1985-1994. Swiss Pneumococcal Study Group.

I Venetz1, K Schopfer, K Mühlemann.   

Abstract

BACKGROUND: Cost effective use of new vaccines against pneumococcal disease in children requires detailed information about the local epidemiology of pneumococcal infections.
METHODS: Data on 393 culture-confirmed cases of invasive pneumococcal infection in children (<17 years) hospitalized in Swiss paediatric clinics were collected retrospectively for the years 1985-1994.
RESULTS: Meningitis (42%) was most frequent, followed by pneumonia (28%) and bacteraemia (26%). The overall annual incidence was 2.7 cases per 100000 children <17 years old and 11 cases per 100000 children <2 years old. Annual incidence rates were stable over the study period. Lethality was high for meningitis (8.6%) and bacteraemia (8.9%). A history of basal skull fracture was reported in 3.3% of children with pneumococcal meningitis. Residence in a rural region was associated with an increased risk of pneumococcal infection (relative risk = 1.45, 95% confidence interval: 1.01-2.00).
CONCLUSIONS: Paediatric, invasive pneumococcal disease seems to be less frequent in Switzerland than in other European and non-European countries. This may be due to differences in diagnostic strategies and lower frequency of risk factors such as the use of day care. Children with a history of basal skull fracture are at increased risk for pneumococcal meningitis. Further investigation of the association of invasive pneumococcal infection with rural residence and the use of antibiotics for upper respiratory tract infections might give new insight into the dynamics of Streptococcus pneumoniae infection and the development of antibiotic resistance.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10024210     DOI: 10.1093/ije/27.6.1101

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  10 in total

Review 1.  New pneumococcal vaccines for children.

Authors:  S Choo; A Finn
Journal:  Arch Dis Child       Date:  2001-04       Impact factor: 3.791

Review 2.  Epidemiology, etiology, pathogenesis, and diagnosis of recurrent bacterial meningitis.

Authors:  Marc Tebruegge; Nigel Curtis
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

Review 3.  The genetic basis of pneumococcal and staphylococcal infections: inborn errors of human TLR and IL-1R immunity.

Authors:  Bertrand Boisson
Journal:  Hum Genet       Date:  2020-01-24       Impact factor: 4.132

4.  Clinical data and factors associated with poor outcome in pneumococcal meningitis.

Authors:  Juan Casado-Flores; Javier Aristegui; Carlos Rodrigo de Liria; Jose María Martinón; Cristina Fernández
Journal:  Eur J Pediatr       Date:  2005-12-07       Impact factor: 3.183

5.  High mortality of invasive pneumococcal disease compared with meningococcal disease in critically ill children.

Authors:  Kentigern Thorburn; Nia Taylor; Lucia Lopez-Rodriguez; Michael Ashworth; Miguel Angel de la Cal; Hendrik Karel Ferdinand van Saene
Journal:  Intensive Care Med       Date:  2005-09-16       Impact factor: 17.440

6.  Burden of paediatric invasive pneumococcal disease in Europe, 2005.

Authors:  E D G McIntosh; B Fritzell; M A Fletcher
Journal:  Epidemiol Infect       Date:  2006-09-07       Impact factor: 2.451

7.  IRAK4 and NEMO mutations in otherwise healthy children with recurrent invasive pneumococcal disease.

Authors:  Cheng-Lung Ku; Capucine Picard; Melinda Erdös; Axel Jeurissen; Jacinta Bustamante; Anne Puel; Horst von Bernuth; Orchidée Filipe-Santos; Huey-Hsuan Chang; Tatiana Lawrence; Marc Raes; László Maródi; Xavier Bossuyt; Jean-Laurent Casanova
Journal:  J Med Genet       Date:  2006-09-01       Impact factor: 6.318

Review 8.  Advances in pneumococcal vaccines: advantages for infants and children.

Authors:  Jolanta Bernatoniene; Adam Finn
Journal:  Drugs       Date:  2005       Impact factor: 9.546

9.  Epidemiologic impact of blood culture practices and antibiotic consumption on pneumococcal bacteraemia in children.

Authors:  A Pérez; M Herranz; M Segura; E Padilla; F Gil; G Durán; F Ferres; A Esteve; D Blanquer; E Bernaola
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-03-18       Impact factor: 3.267

10.  Immunodeficiency among children with recurrent invasive pneumococcal disease.

Authors:  Helene Ingels; Lone Schejbel; A C Lundstedt; Lise Jensen; Inga A Laursen; Lars P Ryder; Niels H H Heegaard; Helle Konradsen; Jens Jørgen Christensen; Carsten Heilmann; Hanne V Marquart
Journal:  Pediatr Infect Dis J       Date:  2015-06       Impact factor: 2.129

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.